Immunicum AB Financial Overview
Immunicum AB's market cap is currently kr292.60M. The company's EPS TTM is kr-0.375; its P/E ratio is -2.42; Immunicum AB is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
